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ORIGINAL ARTICLEFirst detection of mobilized colistin resistancemcr-1 gene in Escherichia coli
isolated from livestock and sewage in IranF. Nikkhahi1, S. Robatjazi1, M. Niazadeh1, A. Javadi2, G. H. Shahbazi1, P. Aris1, S. M. Amin Marashi1 and N. Emam3
1) Medical Microbiology Research Center, 2) Department of Biostatics, Qazvin University of Medical Sciences, Qazvin and 3) Department of Microbiology, School
of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranAbstractCurrently, few studies have investigated the mechanisms of resistance to colistin in Iran. The aim of this study was to investigate mcr-
harbouring Escherichia coli dissemination in livestock and sewage in Iran. A total of 115 samples from cows (n = 38), chickens (n = 47)
and urban sewage samples (n = 30) were collected. The presence of genes including mcr1–6 and ampC β-lactamase (blaMOX, blaCIT,
blaDHA, blaACC, blaEBC, blaFOX) for colistin-resistant isolates was investigated by multiplex PCR method. Genetic association of colistin-
resistant strains was also evaluated by ERIC PCR. Sixty-five isolates were identified as E. coli. Meaningless were resistant to colistin. The
highest (26.1%) and lowest (3.07%) resistance were shown to ampicillin and meropenem respectively. Among the three colistin-resistant
isolates, 2 (66%) were multidrug resistant, with one of them being mcr-1 positive and the other one positive for DHA ampC β-lactamase
gene. No mcr2–6 genes were found. Minimum inhibitory concentration of mcr-producing isolate was 4 mg/L by microbroth dilution. This
study reports, first the detection of mcr-1 in E. coli from farm animals in Iran, a finding that is indicative of a global distribution of this
plasmidic element and threatning the use of colistin as a last resort antibiotic. No clonal relationship was observed between the colistin-
resistant E. coli isolates by ERIC-PCR. Monitoring the presence of these strains in animal sources help as to controlling the spread of
resistance genes from animal to human is vital.
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E-mail: Farhadnikkhahi@gmail.comIntroductionThe increasing prevalence of antibiotic resistance is one of the
global health threats in the 21st century [1]. Escherichia coli (E.
coli) is recognized as one of the major causes of nosocomial in-
fections [1,2], acting as a reservoir of antimicrobial resistance
genes (AMRs). Polymyxins, including polymyxin B and colistin, are
the latest agents for the treatment of infections related to
multidrug resistant gram negative bacteria (MDR-GNB) [2].
These agents primarily bind to the bacterial surface and reduce itsThis is an open access artiintegrity, increase its permeability and ultimately lead to the death
of bacteria [3]. However, the use of colistin has been limited for
treatment considering its nephrotoxic and neurotoxic effects [4].
By 2015, mutations in two-component regulatory systems,
including PmrB, PmrA, PhoP, PhoQ and MgrB, were the only
resistance mechanisms to colistin [5]. The mobilized colistin
resistance (mcr) gene, conferring plasmid-mediated resistance to
colistin, was first detected in China [2,3]. So far, ten different
plasmid-mediated colistin resistance genes have been reported in
the Enterobacteriaceae family. E. coli studies have particularly
demonstrated that poultry and livestock can potentially carry
isolates containing mcr genes; therefore, they can transfer drug-
resistant bacteria to humans. Colistin is widely used in veteri-
nary medicine to treat gastroenteritis in food-producing animals,
especially pigs and poultry [6].
Despite the increasing prevalence of mcr plasmid–mediated
colistin resistance among clinical isolates and the risk ofNew Microbe and New Infect 2021; 41: 100862
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